329 related articles for article (PubMed ID: 17566092)
41. KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer.
Jain M; Zhang L; Patterson EE; Kebebew E
PLoS One; 2011; 6(11):e26866. PubMed ID: 22096502
[TBL] [Abstract][Full Text] [Related]
42. The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor.
Böhlig L; Metzger R; Rother K; Till H; Engeland K
Cell Cycle; 2008 May; 7(9):1254-61. PubMed ID: 18418052
[TBL] [Abstract][Full Text] [Related]
43. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.
Perbal B
Mol Pathol; 2001 Apr; 54(2):57-79. PubMed ID: 11322167
[TBL] [Abstract][Full Text] [Related]
44. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors.
Slater EP; Diehl SM; Langer P; Samans B; Ramaswamy A; Zielke A; Bartsch DK
Eur J Endocrinol; 2006 Apr; 154(4):587-98. PubMed ID: 16556722
[TBL] [Abstract][Full Text] [Related]
45. Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells.
Gellhaus A; Dong X; Propson S; Maass K; Klein-Hitpass L; Kibschull M; Traub O; Willecke K; Perbal B; Lye SJ; Winterhager E
J Biol Chem; 2004 Aug; 279(35):36931-42. PubMed ID: 15181016
[TBL] [Abstract][Full Text] [Related]
46. DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis.
Reincke M; Beuschlein F; Lalli E; Arlt W; Vay S; Sassone-Corsi P; Allolio B
J Clin Endocrinol Metab; 1998 Jul; 83(7):2597-600. PubMed ID: 9661652
[TBL] [Abstract][Full Text] [Related]
47. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression.
Fu CT; Bechberger JF; Ozog MA; Perbal B; Naus CC
J Biol Chem; 2004 Aug; 279(35):36943-50. PubMed ID: 15213231
[TBL] [Abstract][Full Text] [Related]
48. NOV/CCN3 impairs muscle cell commitment and differentiation.
Calhabeu F; Lafont J; Le Dreau G; Laurent M; Kazazian C; Schaeffer L; Martinerie C; Dubois C
Exp Cell Res; 2006 Jun; 312(10):1876-89. PubMed ID: 16600215
[TBL] [Abstract][Full Text] [Related]
49. Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cells.
Mariniello B; Finco I; Sartorato P; Patalano A; Iacobone M; Guzzardo V; Fassina A; Mantero F
J Endocrinol Invest; 2011 Jun; 34(6):e131-8. PubMed ID: 21042045
[TBL] [Abstract][Full Text] [Related]
50. Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors.
Zwermann O; Beuschlein F; Mora P; Weber G; Allolio B; Reincke M
Eur J Endocrinol; 2000 Jun; 142(6):689-95. PubMed ID: 10822234
[TBL] [Abstract][Full Text] [Related]
51. Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults.
Almeida MQ; Soares IC; Ribeiro TC; Fragoso MC; Marins LV; Wakamatsu A; Ressio RA; Nishi MY; Jorge AA; Lerario AM; Alves VA; Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2010 Mar; 95(3):1458-62. PubMed ID: 20080844
[TBL] [Abstract][Full Text] [Related]
52. Transcriptional regulation of P450scc gene expression in neural and steroidogenic cells: implications for regulation of neurosteroidogenesis.
Zhang P; Rodriguez H; Mellon SH
Mol Endocrinol; 1995 Nov; 9(11):1571-82. PubMed ID: 8584034
[TBL] [Abstract][Full Text] [Related]
53. Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors.
Lefrançois-Martinez AM; Bertherat J; Val P; Tournaire C; Gallo-Payet N; Hyndman D; Veyssière G; Bertagna X; Jean C; Martinez A
J Clin Endocrinol Metab; 2004 Jun; 89(6):3010-9. PubMed ID: 15181092
[TBL] [Abstract][Full Text] [Related]
54. Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.
Freddi S; Arnaldi G; Fazioli F; Scarpelli M; Appolloni G; Mancini T; Kola B; Bertagna X; Mantero F; Collu R; Boscaro M
Clin Endocrinol (Oxf); 2005 May; 62(5):533-8. PubMed ID: 15853821
[TBL] [Abstract][Full Text] [Related]
55. MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2.
Zhang G; Zou X; Liu Q; Xie T; Huang R; Kang H; Lai C; Zhu J
Int J Exp Pathol; 2018 Apr; 99(2):77-86. PubMed ID: 29665181
[TBL] [Abstract][Full Text] [Related]
56. Corticotropin-releasing hormone receptor expression on normal and tumorous human adrenocortical cells.
Willenberg HS; Haase M; Papewalis C; Schott M; Scherbaum WA; Bornstein SR
Neuroendocrinology; 2005; 82(5-6):274-81. PubMed ID: 16721033
[TBL] [Abstract][Full Text] [Related]
57. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
58. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.
Gicquel C; Bertagna X; Schneid H; Francillard-Leblond M; Luton JP; Girard F; Le Bouc Y
J Clin Endocrinol Metab; 1994 Jun; 78(6):1444-53. PubMed ID: 7911125
[TBL] [Abstract][Full Text] [Related]
59. The expression of NOV and WT1 in renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
Niu Z; Ito M; Awakura Y; Takahashi T; Nakamura E; Ito N; Ogawa O
J Urol; 2005 Oct; 174(4 Pt 1):1460-2. PubMed ID: 16145471
[TBL] [Abstract][Full Text] [Related]
60. Chicken ovalbumin upstream promoter transcription factor II in the human adrenal cortex and its disorders.
Suzuki T; Takahashi K; Darnel AD; MoriyaT ; Murakami O; Narasaka T; Takeyama J; Sasano H
J Clin Endocrinol Metab; 2000 Aug; 85(8):2752-7. PubMed ID: 10946877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
